L. Sacilotto

发表

QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.

M. Scanavacca, C. Pisani, T. Wu, 2020, Arquivos brasileiros de cardiologia.

Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer

L. Hajjar, M. Scanavacca, T. Wu, 2018, PloS one.

Impact of adherence to warfarin therapy during 12 weeks of pharmaceutical care in patients with poor time in the therapeutic range

A. Pereira, M. Scanavacca, P. C. Santos, 2020, Journal of Thrombosis and Thrombolysis.

Anatomopathological Session Case 2/2008 – A 43-year-old man with hallucinations, nuchal rigidity, seizures, and severe aortic valve dysfunction

V. E. Rosa, L. Sacilotto, M. Teixeira, 2008 .

Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy

J. Krieger, A. Pereira, M. Scanavacca, 2020, Frontiers in Pharmacology.

Effect of Occurrence of Lamin A/C (LMNA) Genetic Variants in a Cohort of 101 Consecutive Apparent “Lone AF” Patients: Results and Insights

J. Krieger, M. Scanavacca, A. Pedrosa, 2022, Frontiers in Cardiovascular Medicine.

Worldwide Survey of COVID-19–Associated Arrhythmias

Angelo B. Biviano, Paul J. Wang, G. Boriani, 2021, Circulation. Arrhythmia and electrophysiology.

Transient ascending ST‐segment depression and widening of the S wave in 3‐channel Holter monitoring—A sign of dromotropic disturbance in the right ventricular outflow tract in the Brugada syndrome: A report of five cases

P. Brugada, A. Pérez-Riera, K. Nikus, 2021, Annals of Noninvasive Electrocardiology.

A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK).

P. Lambiase, R. Hunter, É. Marijon, 2020, JACC. Clinical electrophysiology.

Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1.

S. Priori, A. Mazzanti, N. Monteforte, 2020, Journal of the American College of Cardiology.

Compound Heterozygous SCN5A Mutations in a Toddler - Are they Associated with a More Severe Phenotype?

A. Pereira, M. Scanavacca, T. G. Oliveira, 2017, Arquivos brasileiros de cardiologia.

Is It Safe for Patients With Cardiac Channelopathies to Undergo Routine Dental Care? Experience From a Single‐Center Study

C. Grupi, C. Pastore, N. Samesima, 2019, Journal of the American Heart Association.

Genetic Testing Panels in Inherited Cardiac Diseases-Does Size Really Matter?

C. Semsarian, L. Sacilotto, J. Isbister, 2022, JAMA cardiology.

Low rate of life‐threatening events and limitations in predicting invasive and noninvasive markers of symptoms in a cohort of type 1 Brugada syndrome patients: Data and insights from the GenBra registry

J. Krieger, M. Scanavacca, L. Sacilotto, 2020, Journal of cardiovascular electrophysiology.

Cardiac Arrhythmias and COVID-19: Side-By-Side in the Pandemic.

L. Sacilotto, Bruno Moreira Dos Santos, 2021, Arquivos brasileiros de cardiologia.

2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families

C. Morillo, E. Kaufman, C. Albert, 2020, Heart rhythm.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases

E. Ashley, A. Bollmann, E. Kaufman, 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

E. Ashley, E. Kaufman, E. Behr, 2022, Heart rhythm.

2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families

C. Morillo, E. Kaufman, C. Albert, 2020, Journal of arrhythmia.

Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.

R. Bellazzi, S. Priori, A. Mazzanti, 2018, Journal of the American College of Cardiology.

Catheter Ablation of Focal Atrial Tachycardia with Early Activation Close to the His-Bundle from the Non Coronary Aortic Cusp.

V. Aiello, M. Scanavacca, C. Pisani, 2021, Arquivos brasileiros de cardiologia.

Left Atrial Thrombus and Dense Spontaneous Contrast in Direct Oral Anticoagulant Therapy of Atrial Fibrillation: Insights from a Reference Center.

M. Scanavacca, C. Pisani, T. Wu, 2022, Arquivos brasileiros de cardiologia.

Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin

J. Krieger, A. Pereira, M. Scanavacca, 2018, Front. Pharmacol..

Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range – study protocol for a randomized controlled trial

J. Krieger, A. Pereira, M. Scanavacca, 2016, BMC Cardiovascular Disorders.

Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation

J. Krieger, A. Pereira, M. Scanavacca, 2016, Oncotarget.

3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology

L. Rohde, C. Rochitte, C. Polanczyk, 2017, Arquivos Brasileiros de Cardiologia.